Speaker Profile
Ph.D., Professor, UCSF
Biography
Dr. Lynchs research focuses primarily on the gut and airway microbiome and chronic inflammatory disease. She received her undergraduate and graduate degrees in Microbiology from University College Dublin, Ireland, before postdoctoral training as a Deans Fellow in the Department of Microbiology and Immunology at Stanford University. She has served on a National Academy of Science and Engineering committee and as an American Society of Microbiology, Distinguished Lecturer (2017-2019). She was awarded the Rebecca Buckley Lectureship from the AAAAI in 2015, the Odell lectureship from University of Wisconsin in 2022 and named as one of Foreign Policy Magazines "Global Thinkers" in 2016. She co-founded Siolta Therapeutics Inc. a biotech company whose lead live biotherapeutic for the prevention of childhood atopy and asthma is in human trials.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Keith Yamamoto, UCSF
- PMWC 2025 Award Ceremony:
Pioneer Honoree: Robert Califf, FDA
Luminary Honoree: Ida Sim, UCSF
- Fireside Chat: Keith Yamamoto, UCSF, Robert Califf, FDA, and Kathy Giacomini, UCSF
- Keynote: TBA
- Ida Sim, UCSF
- AI-driven Advances in Precision Medicine (PANEL)
Chair: Sharat Israni, Bakar Institute, UCSF
- Peter Norvig, Google
- Susan Lynch, UCSF
- New Federal Programs Driving Transformative Health Breakthrough (PANEL)
Chair: Keith Yamamoto, UCSF
- Susan Monarez, ARPA-H
- Charles Romine, NIST
- Erwin Gianchandani, NSF - AI-Driven Protein Design (PANEL)
Chair:
- AI and Ethical Challenges (PANEL)
Chair: Ida Sim, UCSF
- Jianying Hu, IBM
